4.7 Article

Antineoplastic Agents. 454. Synthesis of the Strong Cancer Cell Growth Inhibitors trans-Dihydronarciclasine and 7-Deoxy-trans-dihydronarciclasine

Journal

JOURNAL OF NATURAL PRODUCTS
Volume 72, Issue 7, Pages 1279-1282

Publisher

AMER CHEMICAL SOC
DOI: 10.1021/np9001948

Keywords

-

Funding

  1. Division of Cancer Treatment and Diagnosis [CA-44344-01A1-10-12, RO1-CA90441-01-03, 5RO1-CA090441-07]
  2. National Cancer Institute
  3. DHHS
  4. Arizona Disease Control Research Commission
  5. Fannie E. Rippel Foundation
  6. Robert B. Dalton Endowment Fund

Ask authors/readers for more resources

To further pursue the antineoplastic leads offered by Our isolation of trans-dihydronarciclasine (1a) and 7-deoxy-trans-dihydronarciclasine (1c) from two medicinal plant species of the Amaryllidaceae family, a practical palladium-catalyzed hydrogenation procedure was developed for the synthesis of these isocarbostyrils from narciclasine (2a) and 7-deoxynarciclasine (2c).

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available